Overview
Naomi Shimizu practices in Sakura, Japan. Ms. Shimizu is rated as an Experienced expert by MediFind in the treatment of Wilms Tumor. Her top areas of expertise are Pyridoxine Deficiency, Familial Wilms Tumor 2, POEMS Syndrome, Sideroblastic Anemia, and Bone Marrow Transplant.
Her clinical research consists of co-authoring 56 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Wilms Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Wilms Tumor 2Ms. Shimizu isAdvanced. Learn about Familial Wilms Tumor 2.
- POEMS SyndromeMs. Shimizu isAdvanced. Learn about POEMS Syndrome.
- Pyridoxine DeficiencyMs. Shimizu isAdvanced. Learn about Pyridoxine Deficiency.
- Sideroblastic AnemiaMs. Shimizu isAdvanced. Learn about Sideroblastic Anemia.
- Experienced
- AnemiaMs. Shimizu isExperienced. Learn about Anemia.
- AtherosclerosisMs. Shimizu isExperienced. Learn about Atherosclerosis.
- B-Cell LymphomaMs. Shimizu isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMs. Shimizu isExperienced. Learn about Bone Marrow Transplant.
- Diffuse Large B-Cell Lymphoma (DLBCL)Ms. Shimizu isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Familial HypertriglyceridemiaMs. Shimizu isExperienced. Learn about Familial Hypertriglyceridemia.